Behind BioMed’s Buying Spree

Investors in life science developer BioMed Realty’s parent, a Blackstone Real Estate fund, were in no hurry to cash out and take their profits in 2020 as the pandemic was making the biopharma sector more attractive than ever. So the private equity giant gave them a new, multi-billion-dollar option. 

Who Pays to Bail Out Boston?

With potential for massive property damage in Boston neighborhoods in the path of rising seas, the city is studying funding mechanisms to pick up the multi-billion-dollar tab in coming decades.